Webinar Date & Time
18 March 2026 from 03:00 PM to 04:30 PM (CET)
Webinar Overview
ICH GCP is changing — and so is the meaning of “risk management.”
With ICH GCP R3, regulators are no longer interested in perfect paperwork. They are interested in clear thinking, proportional controls, and real protection of patients and data.
This webinar goes beyond theory.
What you will really learn
- The true risk-management logic of ICH R3 — what regulators mean, not just what the text says
- The most common mistakes CROs make when applying risk-based approaches (and why they keep repeating them)
- Why many “Risk Management Plans” look impressive — but fail under inspection
- How CROs, as a core execution engine of clinical trials, must manage not only trial risks, but organizational risks
- Where the line actually is between trial risk and company-level risk under ICH R3
A unique perspective you won’t get from guidance documents. This session includes a real-world perspective from a Ukrainian CRO that has conducted trials through war-time disruptions, infrastructure instability and a sudden operational shocks.
Not as a dramatic story — but as a practical lesson in what real business continuity looks like when patient safety and data integrity must not stop.
Presenter
Yurii Lebid, MD, PhD
CEO
Pharmaxi LLC
Yurii Lebid is the Founder and CEO of Pharmaxi LLC, a Contract Research Organization established in 2013 in Kyiv, Ukraine. With a background in medicine and academic science, Yurii combines scientific rigor with pragmatic operational leadership, setting high standards for quality, reliability, and execution.
Under his leadership, Pharmaxi has grown from a two-person startup into a team of nearly 30 professionals and has become a trusted CRO in Eastern Europe, recognized for its operational efficiency, transparency, and resilience. A strong advocate of collaboration, Yurii initiated the Pharmaxi Partnership Network, which today unites more than 60 companies involved in clinical research across Europe and beyond. This collaborative approach proved critical to the company’s continuity during both the COVID-19 pandemic and the ongoing war in Ukraine.
Over the past 12 years, Pharmaxi has operated through multiple layers of disruption — financial, political, military, and energy-related. As a result, risk management within the company is not a theoretical exercise, but a discipline tested under real and extreme conditions.
In this webinar, Yurii shares a CRO’s perspective on ICH GCP R3 risk management — focusing not only on trial-level risks, but also on organizational resilience and continuity as essential components of sustainable, inspection-ready clinical research operations.
Attendance Fee
€ 90,- for non-EUCROF members
€ 60,- for EUCROF members
Deadline for registration
17 March 2026 at 6 p.m.
How to register?
1) Go on the REGISTRATION PAGE and click on the orange button “GET TICKETS”
2) Check your order and click on the green “CHECKOUT” button
3) Fill in all the necessary information and validate your order
Confirmation
You will receive 2 confirmation emails:
A) One from Eventbrite with your invoice
B) One from “Eucrof” with all the necessary information to connect the D-Day!
Questions?
Should you have any questions about registration, invoices or connection, do not hesitate and contact us by email at webinar@eucrof.eu
By registering to the webinar, you give your authorisation to the webinar organizers to use your email address and personal information to communicate with you about this event and future initiatives. To stop receiving their communications, please contact the organizers directly at info@eucrof.eu.
